Thadhani, Ravi
Willetts, Joanna
Wang, Catherine
Larkin, John
Zhang, Hanjie
Fuentes, Lemuel Rivera
Usvyat, Len
Belmonte, Kathleen
Wang, Yuedong
Kossmann, Robert
Hymes, Jeffrey
Kotanko, Peter
Maddux, Franklin
Funding for this research was provided by:
Fresenius Medical Care North America (NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA)
National Institute of Diabetes and Digestive and Kidney Diseases (R01DK130067, R01DK130067)
Article History
Received: 13 May 2021
Accepted: 6 September 2021
First Online: 16 September 2021
Declarations
:
: This analysis was performed under a regulatory protocol that was reviewed by New England Institutional Review Board (Needham Heights, MA, United States; NEIRB WO#: 17-1349084-1). The Institutional Review Board approved the protocol under an Exempt Category due to use of deidentified data that did not contain any Protected Health Information and informed consent (written or verbal) was not required or applicable per the United States Code of Federal Regulations (45 CFR 46.104-d4ii). Analysis was conducted in adherence with Declaration of Helsinki.
: Not applicable.
: R.T. reports employment at Mass General Brigham; reports having consultancy agreements with Fresenius Medical Care, and Biogen Idec; reports receiving honoraria from Roche Diagnostics; reports ownership interests in Aggamin LLC; reports receiving research funding from the National Institutes of Health, Kaneka Corp, Diasorin, and ThermoFisher; reports having patents and invention interests that include ThermoFisher and Up-To-Date; reports being a scientific advisor to Aggamin LLC. J.W. reports employment at Fresenius Medical Care. J.L. reports employment at Fresenius Medical Care; reports being an inventor on patent in the field of dialysis; reports being a guest editor on the Editorial Board of Frontiers in Physiology. H.Z. reports employment at Renal Research Institute, a wholly owned subsidiary of Fresenius Medical Care. L.R.F. reports employment at Renal Research Institute, a wholly owned subsidiary of Fresenius Medical Care. L.U. reports employment at Fresenius Medical Care; reports having share options/ownership in Fresenius Medical Care; reports being an inventor on multiple patents in the field of dialysis. K.B. reports employment at Fresenius Medical Care; reports having share options/ownership in Fresenius Medical Care; reports being an inventor on patent in the field of dialysis. Y.W. reports receiving research funding from the National Institutes of Health and Fresenius Medical Care. R.K. reports employment at Fresenius Medical Care; reports having share options/ownership in Fresenius Medical Care. J.H. reports employment at Fresenius Medical Care; reports having share options/ownership in Fresenius Medical Care; reports being an inventor on patent in the field of dialysis. P.K. reports employment at Renal Research Institute, a wholly owned subsidiary of Fresenius Medical Care; reports having share options/ownership in Fresenius Medical Care; reports being an inventor on multiple patents in the field of dialysis; reports being on the Editorial Board of Blood Purification and Kidney and Blood Pressure Research. F.M. reports employment at Fresenius Medical Care; reports having share options/ownership in Fresenius Medical Care; reports being an inventor on multiple patents in the field of dialysis; reports having directorships in Fresenius Medical Care Management Board, Goldfinch Bio, and Vifor Fresenius Medical Care Renal Pharma. All remaining authors have nothing to disclose.